Regentis Biomaterials Ltd. (RGNT)

CIK 1912966 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Regentis Biomaterials Ltd..

Recent SEC filings

FiledFormAccession number
Sep 11, 20266-K0001213900-26-099007
Aug 13, 2026SCHEDULE 13G0001622627-26-000021
Aug 11, 2026S-80001213900-26-087550
Jul 20, 20266-K0001213900-26-079444
Jul 15, 20266-K0001213900-26-078150
Jul 13, 2026EFFECT9999999995-26-002284
Jul 13, 202640001213900-26-077638
Jul 13, 202640001213900-26-077631
Jul 13, 202640001213900-26-077636
Jul 13, 2026424B30001213900-26-077637
Jul 13, 202640001213900-26-077634
Jul 13, 202640001213900-26-077633
Jul 13, 202640001213900-26-077622
Jul 9, 20266-K0001213900-26-076745
Jul 8, 2026F-10001213900-26-076392
Jul 2, 20266-K0001213900-26-075015
Jun 25, 2026D0001213900-26-072125
Jun 18, 20266-K0001213900-26-070229
Jun 15, 2026RW0001213900-26-068596
Jun 15, 20266-K0001213900-26-068601
Jun 9, 2026F-1/A0001213900-26-066555
Jun 8, 20266-K0001213900-26-066070
Jun 4, 20266-K/A0001213900-26-065320
May 29, 2026FWP0001213900-26-062753
May 28, 20266-K0001213900-26-062168